Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr. Reddy’s recalls over 80,000 bottles of Atorvastatin Calcium Tablets from US market

Date: 09-02-2018

Dr. Reddy’s Laboratories has initiated voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and 40mg from the US market due to quality concerns. Atorvastatin is a drug that blocks the production of cholesterol and reduces its level in the blood.

The company has recalled multiple lots of Atorvastatin 10 mg, 90 count and 500 count bottles; 20 mg, 90 count and 500 count bottles and 40 mg, 90 count bottles from US market.

The company has recalled the drug on account of Failed Impurities/Degradations specifications; out-of-specification results observed for Total Degradation Impurities during stability. The drug was manufactured at the drug maker’s Srikakulam plant in Andhra Pradesh.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.